Search

Your search keyword '"Tedeschi G"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Tedeschi G" Remove constraint Author: "Tedeschi G" Topic neurology Remove constraint Topic: neurology
125 results on '"Tedeschi G"'

Search Results

1. The future of neurology after the COVID-19 pandemic according to neurology residents.

2. Digital therapeutics in neurology.

3. The contribution of the Italian residents in neurology to the COVID-19 crisis: admirable generosity but neurological training remains their priority.

4. COVID-19 impact on neurology training program in Italy.

5. Stroke and digital technology: a wake-up call from COVID-19 pandemic.

6. Coverage of the requirements of first and second level stroke unit in Italy.

7. Dementia care and COVID-19 pandemic: a necessary digital revolution.

8. Neurology and the COVID-19 emergency.

9. Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP).

10. Assessing disability and relapses in multiple sclerosis on tele-neurology.

11. Neurology and the Internet: a review.

12. Functional neuroimaging in migraine: usefulness for the clinical neurologist.

13. The role of emergency neurology in Italy: outcome of a consensus meeting for a Intersociety position.

15. Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative

16. Signs and symptoms of COVID-19 in patients with multiple sclerosis

17. HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine?

18. MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis

19. Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

20. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

21. The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS

22. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

23. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

24. Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study

25. Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study

26. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

27. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

28. The pharmacovigilance program on natalizumab in Italy: 2 years of experience.

29. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

30. Opinion, knowledge, and clinical experience with functional neurological disorders among Italian neurologists: results from an online survey

31. Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis

32. Disability assessment using Google Maps

33. Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients

34. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

35. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

36. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

37. Dementia care and COVID-19 pandemic: a necessary digital revolution

38. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension

39. Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

40. Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis

41. Development and Validation of Automated <scp>Magnetic Resonance</scp> Parkinsonism Index 2.0 to Distinguish <scp>Progressive Supranuclear Palsy‐Parkinsonism</scp> From <scp>Parkinson's Disease</scp>

42. Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set

43. Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study

44. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

45. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

46. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability

47. Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project

48. Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment

49. Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study

50. Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)

Catalog

Books, media, physical & digital resources